Jana Coombs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jana Coombs has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bert K. Lopansri
University of Utah
3 shared publications - Andy Nguyen
Affiliation Global Blood Therapeutics, Inc., South San Francisco, California, United States of America
1 shared publication Birgitta Mitchell
Intermountain Blood and Marrow Transplant Program, LDS Hospital, Salt Lake City, Utah
1 shared publication- Brandon J. Webb
Division of Clinical Epidemiology and Infectious Diseases, Intermountain Medical Center
1 shared publication Brandon Webb
Division of Infectious Diseases and Clinical Epidemiology, LDS Hospital, Salt Lake City, Utah; Division of Infectious Diseases, University of Utah, Salt Lake City, Utah
1 shared publication- Clyde D. Ford
Intermountain Blood and Marrow Transplant Program, LDS Hospital, Salt Lake City, Utah
1 shared publication
Latest Publications
- 18 September 2019
- Published by Wiley in Clinical Transplantation
- Vol. 33 (11) , e13712
Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes
Background: More data are needed regarding the incidence, risk factors, and outcomes for Clostridioides difficile infection (CDI) and colonization in patients undergoing an autologous hematopoietic stem cell transplantation (AHSCT).Methods: We studied 472 consecutive patients admitted for a first AHSCT and conducted a prospective C difficile stool surveillance and ribotyping analysis in a subset of 94 patients.Results: Clostridioides difficile infection was diagnosed in 7% of patients for an incidence of 3.4 CDI/1000 inpatient days, recurrent/reinfection CDI was rare. CDI was increased in patients who were colonized on admission, had required a recent pre‐admission inpatient stay for fever and/or serious infection, or received empiric therapy with a carbapenem or extended‐spectrum penicillin. CDI was associated with a longer length of stay and higher hospital costs. Twelve of 94 patients (13%) were found to have colonization on admission; CDI was diagnosed in 27% of these vs 1% in those with initial negative stools. Colonization in the hospital for those negative on admission was infrequent. C difficile ribotyping showed a predominance of 014/020.Conclusions: Clostridioides difficile infection is a significant infection in patients receiving a first AHSCT. The risk factors identified may be useful in designing preventive interventions.
- 18 September 2019
- Published by Wiley in Clinical Transplantation
- Vol. 33 (11) , e13712
Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes
Background: More data are needed regarding the incidence, risk factors, and outcomes for Clostridioides difficile infection (CDI) and colonization in patients undergoing an autologous hematopoietic stem cell transplantation (AHSCT).Methods: We studied 472 consecutive patients admitted for a first AHSCT and conducted a prospective C difficile stool surveillance and ribotyping analysis in a subset of 94 patients.Results: Clostridioides difficile infection was diagnosed in 7% of patients for an incidence of 3.4 CDI/1000 inpatient days, recurrent/reinfection CDI was rare. CDI was increased in patients who were colonized on admission, had required a recent pre‐admission inpatient stay for fever and/or serious infection, or received empiric therapy with a carbapenem or extended‐spectrum penicillin. CDI was associated with a longer length of stay and higher hospital costs. Twelve of 94 patients (13%) were found to have colonization on admission; CDI was diagnosed in 27% of these vs 1% in those with initial negative stools. Colonization in the hospital for those negative on admission was infrequent. C difficile ribotyping showed a predominance of 014/020.Conclusions: Clostridioides difficile infection is a significant infection in patients receiving a first AHSCT. The risk factors identified may be useful in designing preventive interventions.
- Open Access
- 1 February 2017
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (2) , 340-346
Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes
- 1 February 2017
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (2) , 340-346
Open AccessVancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes
- Open Access
- 1 February 2016
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 54 (2) , 312-316
Comparison of Two Culture Methods for Use in Assessing Microbial Contamination of Duodenoscopes
Recent outbreaks of carbapenem-resistant Enterobacteriaceae infections associated with duodenoscopes used for endoscopic retrograde cholangiopancreatography have highlighted the challenge of cleaning and high-level disinfection of these instruments. The Food and Drug Administration has suggested that duodenoscope surveillance by microbiological culturing, along with strict adherence to reprocessing protocols, may help reduce the risk of duodenoscope-associated infection transmission. We developed and validated an effective, user-friendly duodenoscope sampling and culture protocol and compared its performance to the interim Centers for Disease Control and Prevention–recommended guidelines. Our protocol resulted in a 65% recovery rate for Gram-negative organisms, demonstrating a 2-fold increased recovery rate compared to the CDC method. The implementation of this protocol may increase the feasibility of duodenoscope surveillance for microbiology laboratories and endoscopy departments.
- 1 February 2016
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 54 (2) , 312-316
Open AccessComparison of Two Culture Methods for Use in Assessing Microbial Contamination of Duodenoscopes
Recent outbreaks of carbapenem-resistant Enterobacteriaceae infections associated with duodenoscopes used for endoscopic retrograde cholangiopancreatography have highlighted the challenge of cleaning and high-level disinfection of these instruments. The Food and Drug Administration has suggested that duodenoscope surveillance by microbiological culturing, along with strict adherence to reprocessing protocols, may help reduce the risk of duodenoscope-associated infection transmission. We developed and validated an effective, user-friendly duodenoscope sampling and culture protocol and compared its performance to the interim Centers for Disease Control and Prevention–recommended guidelines. Our protocol resulted in a 65% recovery rate for Gram-negative organisms, demonstrating a 2-fold increased recovery rate compared to the CDC method. The implementation of this protocol may increase the feasibility of duodenoscope surveillance for microbiology laboratories and endoscopy departments.